Anti-interleukin-12 antibody treatment for Crohn disease: potential risk of invasive disease due to mycobacteria and salmonellae infection.
MacLennan
Calman
C
Lammas
David A
DA
Kumararatne
Dinakantha S
DS
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy*; D006801:Humans; D018664:Interleukin-12 / Q000276:immunology*; D009164:Mycobacterium Infections / Q000150:complications*; D012480:Salmonella Infections / Q000150:complications*
D000911:Antibodies, Monoclonal; D018664:Interleukin-12